FSHR rs12294113: What Your Genotype Means

What each genotype means

Understanding the SNP and the FSHR Gene

The rs12294113 variant is a specific change in the DNA sequence of the FSHR gene, which stands for follicle-stimulating hormone receptor. This gene provides instructions for making a protein that sits on the surface of certain cells in the ovaries and testes. In the ovaries, this receptor is essential for the development of follicles, which contain eggs. When follicle-stimulating hormone (FSH) binds to this receptor, it triggers a signaling cascade that promotes follicle growth and maturation. Because this receptor is the primary gateway for FSH action, scientists have long hypothesized that variations in the gene sequence might alter the receptor's sensitivity or density, potentially leading to differences in how an individual's ovaries react to both natural hormone cycles and the exogenous hormones administered during fertility treatments.

Research on Ovarian Stimulation

In the context of assisted reproductive technology (ART), such as in vitro fertilization (IVF), clinicians often use gonadotropins to stimulate the ovaries to produce multiple eggs. Studies have explored whether specific FSHR variants, including rs12294113, correlate with the number of oocytes retrieved or the total dose of medication required for a successful cycle. While some research suggests that certain FSHR genotypes may be associated with variations in ovarian responsiveness, the evidence remains limited and sometimes conflicting. Many studies indicate that while genetic factors play a role, the response to stimulation is a complex, polygenic trait influenced by many genes, as well as environmental and clinical factors like age and baseline hormone levels. Consequently, current clinical guidelines generally do not recommend routine genotyping for this specific SNP to guide treatment, as the clinical impact of the variant alone is often considered minimal.

Population Frequency and Diversity

Genetic variants like rs12294113 are distributed differently across global populations. Data indicates that the minor allele frequency for this variant is approximately 0.40 in European populations and roughly 0.32 in East Asian populations. These frequencies highlight that the variant is relatively common rather than rare. It is important to note that genetic associations observed in one ancestral group may not always replicate in others due to differences in genetic background and linkage disequilibrium—the tendency of certain DNA segments to be inherited together. Because of this, researchers emphasize the need for large, diverse studies to fully understand how this variant interacts with other genetic and non-genetic factors across different populations.

What This Information Means for You

If you have received information about your FSHR genotype, it is important to interpret it within the context of your overall health and clinical history. This variant is not a diagnostic tool for infertility, nor does it definitively predict the outcome of a fertility treatment cycle. Because the evidence linking rs12294113 to specific clinical outcomes is limited and often shows only small effects, it should not be used to make independent medical decisions. If you are undergoing fertility treatment or have concerns about ovarian response, the most reliable approach is to discuss your specific clinical profile with a reproductive endocrinologist. They can integrate your genetic information, if relevant, with established clinical markers like anti-Müllerian hormone (AMH) levels and antral follicle counts to personalize your care plan. Never adjust medication dosages based on genetic reports without direct guidance from your healthcare provider.

Frequently asked questions

Sources & further reading

Related variants in FSHR